☰

Ádám Vas - Publications

Affiliations: 
University of Szeged, Szeged, Hungary 
Area:
neuropharmacology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Gulyás B, Tóth M, Schain M, Airaksinen A, Vas A, Kostulas K, Lindström P, Hillert J, Halldin C. Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine. Journal of the Neurological Sciences. 320: 110-7. PMID 22841414 DOI: 10.1016/J.Jns.2012.06.026  0.543
2012 Gulyas B, Toth M, Vas A, Shchukin E, Kostulas K, Hillert J, Halldin C. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine. Current Radiopharmaceuticals. 5: 19-28. PMID 22074478 DOI: 10.2174/1874471011205010019  0.608
2012 Szilágyi G, Vas A, Kerényi L, Nagy Z, Csiba L, Gulyás B. Correlation between crossed cerebellar diaschisis and clinical neurological scales. Acta Neurologica Scandinavica. 125: 373-81. PMID 21781057 DOI: 10.1111/J.1600-0404.2011.01576.X  0.512
2011 Gulyás B, Vas A, Tóth M, Takano A, Varrone A, Cselényi Z, Schain M, Mattsson P, Halldin C. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine. Neuroimage. 56: 1111-21. PMID 21320609 DOI: 10.1016/J.Neuroimage.2011.02.020  0.542
2008 Vas A, Shchukin Y, Karrenbauer VD, Cselényi Z, Kostulas K, Hillert J, Savic I, Takano A, Halldin C, Gulyás B. Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients. Journal of the Neurological Sciences. 264: 9-17. PMID 17727889 DOI: 10.1016/J.Jns.2007.07.018  0.627
2005 Vas A, Gulyás B. Eburnamine derivatives and the brain. Medicinal Research Reviews. 25: 737-57. PMID 16158388 DOI: 10.1002/med.20043  0.615
2005 Szilágyi G, Nagy Z, Balkay L, Boros I, Emri M, Lehel S, Márián T, Molnár T, Szakáll S, Trón L, Bereczki D, Csiba L, Fekete I, Kerényi L, Galuska L, et al. Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study. Journal of the Neurological Sciences. 229: 275-84. PMID 15760651 DOI: 10.1016/J.Jns.2004.11.053  0.608
2005 Gulyás B, Halldin C, Vas A, Banati RB, Shchukin E, Finnema S, Tarkainen J, Tihanyi K, Szilágyi G, Farde L. [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. Journal of the Neurological Sciences. 229: 219-23. PMID 15760643 DOI: 10.1016/J.Jns.2004.11.032  0.607
2003 Vas A, Christer H, Sóvágó J, Johan S, Cselényi Z, Kiss B, Kárpáti E, Lars F, Gulyás B. [Human positron emission tomography with oral 11C-vinpocetine]. Orvosi Hetilap. 144: 2271-6. PMID 14702922  0.63
2002 Vas A, Sóvágó J, Halldin C, Sandell J, Karlsson P, Kárpáti E, Kiss B, Cselényi Z, Farde L, Gulyás B. [Cerebral uptake and regional distribution of [11C]-vinpocetin after intravenous administration to healthy men: a PET study]. Orvosi Hetilap. 143: 2631-6. PMID 12532649  0.677
2002 Gulyás B, Halldin C, Sandell J, Karlsson P, Sóvágó J, Kárpáti E, Kiss B, Vas A, Cselényi Z, Farde L. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects. Acta Neurologica Scandinavica. 106: 325-32. PMID 12460136 DOI: 10.1034/J.1600-0404.2002.01302.X  0.651
2002 Vas A, Gulyás B, Szabó Z, Bönöczk P, Csiba L, Kiss B, Kárpáti E, Pánczél G, Nagy Z. Clinical and non-clinical investigations using positron emission tomography, near infrared spectroscopy and transcranial Doppler methods on the neuroprotective drug vinpocetine: a summary of evidences. Journal of the Neurological Sciences. 203: 259-62. PMID 12417394 DOI: 10.1016/S0022-510X(02)00301-5  0.673
2002 Gulyás B, Vas A, Halldin C, Sóvágó J, Sandell J, Olsson H, Fredriksson A, Stone-Elander S, Farde L. Cerebral uptake of [ethyl-11C]vinpocetine and 1-[11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. Nuclear Medicine and Biology. 29: 753-9. PMID 12381455 DOI: 10.1016/S0969-8051(02)00319-0  0.549
2002 Gulyás B, Halldin C, Sóvágó J, Sandell J, Cselényi Z, Vas A, Kiss B, Kárpáti E, Farde L. Drug distribution in man: a positron emission tomography study after oral administration of the labelled neuroprotective drug vinpocetine. European Journal of Nuclear Medicine and Molecular Imaging. 29: 1031-8. PMID 12173017 DOI: 10.1007/S00259-002-0823-4  0.585
2002 Hall H, Varnäs K, Sandell J, Halldin C, Farde L, Vas A, Kárpáti E, Gulyás B. Autoradiographic evaluation of [11C]vinpocetine binding in the human postmortem brain. Acta Biologica Hungarica. 53: 59-66. PMID 12064779 DOI: 10.1556/ABiol.53.2002.1-2.7  0.557
2001 Gulyás B, Bönöczk P, Vas A, Csiba L, Bereczki D, Boros I, Szakáll S, Balkay L, Emri M, Fekete I, Galuska L, Kerényi L, Lehel S, Márián T, Molnár T, et al. [The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke]. Orvosi Hetilap. 142: 443-9. PMID 11301903  0.566
2000 Bönöczk P, Gulyás B, Adam-Vizi V, Nemes A, Kárpáti E, Kiss B, Kapás M, Szántay C, Koncz I, Zelles T, Vas A. Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Research Bulletin. 53: 245-54. PMID 11113577 DOI: 10.1016/S0361-9230(00)00354-3  0.604
Show low-probability matches.